Topical Ruxolitinib for the Treatment of Alopecia Universalis

被引：73

作者：

Craiglow, Brittany G. ^{[1
]}

Tavares, Daniel ^{[2
]}

King, Brett A. ^{[1
]}

机构：

[1] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA

[2] Qual Care Drug, Centerbrook, CT USA

来源：

JAMA DERMATOLOGY | 2016年 / 152卷 / 04期

关键词：

PLAQUE PSORIASIS; TOFACITINIB;

D O I：

10.1001/jamadermatol.2015.4445

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100227 [皮肤病学];

摘要：

[No abstract available]

引用

收藏

页码：490 / 491

页数：3

相关论文

共 3 条

[1]

Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis [J].

Craiglow, Brittany G. ;

King, Brett A. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (12) :2988-2990

[2]

A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis [J].

Ports, W. C. ;

Khan, S. ;

Lan, S. ;

Lamba, M. ;

Bolduc, C. ;

Bissonnette, R. ;

Papp, K. .

BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (01) :137-145

[3]

Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition [J].

Xing, Luzhou ;

Dai, Zhenpeng ;

Jabbari, Ali ;

Cerise, Jane E. ;

Higgins, Claire A. ;

Gong, Weijuan ;

de Jong, Annemieke ;

Harel, Sivan ;

DeStefano, Gina M. ;

Rothman, Lisa ;

Singh, Pallavi ;

Petukhova, Lynn ;

Mackay-Wiggan, Julian ;

Christiano, Angela M. ;

Clynes, Raphael .

NATURE MEDICINE, 2014, 20 (09) :1043-1049